David A Nace

InstitutionUniversity of Pittsburgh
AddressPittsburgh
Pennsylvania
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 9 Covid-19 publications, with a maximum of 3 publications in June 2020
    All Publications
    Bar chart showing 47 publications over 18 distinct years, with a maximum of 8 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Weber DJ, Al-Tawfiq JA, Babcock HM, Bryant K, Drees M, Elshaboury R, Essick K, Fakih M, Henderson DK, Javaid W, Juffras D, Jump RLP, Lee F, Malani AN, Mathew TA, Murthy RK, Nace D, O'Shea T, Pettigrew E, Pettis AM, Schaffzin JK, Shenoy ES, Vaishampayan J, Wiley Z, Wright SB, Yokoe D, Young H. Multisociety statement on coronavirus disease 2019 (COVID-19) vaccination as a condition of employment for healthcare personnel. Infect Control Hosp Epidemiol. 2022 01; 43(1):3-11. PMID: 34253266.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    2. Nace DA, Kip KE, Mellors JW, Peck Palmer OM, Shurin MR, Mulvey K, Crandall M, Sobolewski MD, Enick PN, McCormick KD, Jacobs JL, Kane AL, Lukanski A, Kip PL, Wells A. Antibody Responses After mRNA-Based COVID-19 Vaccination in Residential Older Adults: Implications for Reopening. J Am Med Dir Assoc. 2021 Aug; 22(8):1593-1598. PMID: 34129831.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    3. Huang DT, McCreary EK, Bariola JR, Wadas RJ, Kip KE, Marroquin OC, Koscumb S, Collins K, Shovel JA, Schmidhofer M, Wisniewski MK, Sullivan C, Yealy DM, Axe M, Nace DA, Haidar G, Khadem T, Linstrum K, Snyder GM, Seymour CW, Montgomery SK, McVerry BJ, Berry L, Berry S, Meyers R, Weissman A, Peck-Palmer OM, Wells A, Bart R, Albin DL, Minnier T, Angus DC. The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization. Trials. 2021 May 25; 22(1):363. PMID: 34034784.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    4. Bariola JR, McCreary EK, Wadas RJ, Kip KE, Marroquin OC, Minnier T, Koscumb S, Collins K, Schmidhofer M, Shovel JA, Wisniewski MK, Sullivan C, Yealy DM, Nace DA, Huang DT, Haidar G, Khadem T, Linstrum K, Seymour CW, Montgomery SK, Angus DC, Snyder GM. Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Open Forum Infect Dis. 2021 Jul; 8(7):ofab254. PMID: 34250192.
      Citations: 4     
    5. Bariola JR, McCreary EK, Khadem T, Snyder GM, Wadas RJ, Nace DA, White DB, Yealy DM, Schmidhofer M. Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy Across a Large Health System During a Global Pandemic. Open Forum Infect Dis. 2021 Jul; 8(7):ofab151. PMID: 34322560.
      Citations: 1     
    6. Dumyati G, Gaur S, Nace DA, Jump RLP. Does Universal Testing for COVID-19 Work for Everyone? J Am Med Dir Assoc. 2020 11; 21(11):1525-1532. PMID: 32958402.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    7. Laxton CE, Nace DA, Nazir A. Solving the COVID-19 Crisis in Post-Acute and Long-Term Care. J Am Med Dir Assoc. 2020 Jul; 21(7):885-887. PMID: 32674813.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    8. Gaur S, Pandya N, Dumyati G, Nace DA, Pandya K, Jump RLP. A Structured Tool for Communication and Care Planning in the Era of the COVID-19 Pandemic. J Am Med Dir Assoc. 2020 07; 21(7):943-947. PMID: 32674824.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    9. Gaur S, Dumyati G, Nace DA, Jump RLP. Unprecedented solutions for extraordinary times: Helping long-term care settings deal with the COVID-19 pandemic. Infect Control Hosp Epidemiol. 2020 06; 41(6):729-730. PMID: 32223767.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    10. Kodama F, Nace DA, Jump RLP. Respiratory Syncytial Virus and Other Noninfluenza Respiratory Viruses in Older Adults. Infect Dis Clin North Am. 2017 12; 31(4):767-790. PMID: 29079159.
      Citations: 10     Fields:    Translation:HumansCellsPHPublic Health